# In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung

> **NCT05611034** · PHASE1 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 10 (estimated)

## Conditions studied

- Lung Metastases
- Colorectal Cancer Metastatic
- Colorectal Cancer

## Interventions

- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT05611034
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-06
- **Primary completion:** 2026-08-01
- **Final completion:** 2032-01-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05611034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05611034, "In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05611034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*